tetradecanoylphorbol acetate has been researched along with sesamin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamano, T; Konoshima, T; Takasaki, M; Tokuda, H; Yasuda, I | 1 |
| Bae, JS; Han, CK; Ku, SK; Lee, W; Yoo, H | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and sesamin
| Article | Year |
|---|---|
Inhibitory effects of shouseiryu-to on two-stage carcinogenesis. II. Anti-tumor-promoting activities of lignans from Asiasarum heterotropoides var. mandshuricum.
Topics: Animals; Anticarcinogenic Agents; Antigens, Viral; Cell Line; Cell Transformation, Neoplastic; Dioxoles; Female; Furans; Lignans; Lung Neoplasms; Mice; Mice, Inbred ICR; Phenols; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1997 |
Inhibitory effects of epi-sesamin on endothelial protein C receptor shedding in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antigens, CD; Cells, Cultured; Dioxoles; Endothelial Protein C Receptor; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; Lignans; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Receptors, Cell Surface; Sepsis; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2013 |